kiniksa pharmaceuticals international plc nasdaqknsa receives 56 00 average price target from brokerages

TAX_DISEASE_CRYOPYRINASSOCIATED_PERIODIC_SYNDROMESTAX_DISEASE_ADULTONSET_STILL_DISEASETAX_FNCACT_CANDIDATESTAX_DISEASE_DISEASE

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.